Mesenchymal Stem Cell Therapy in Ischaemic Heart Failure: Hope or Hype?

Ischaemic heart diseases (IHDs) are the leading contributor to mortality worldwide and more than 60% occur in low-to-middle-income countries (LMICs) and 40% of these are specified as premature. Despite notable improvements in treatment options, premature deaths due to IHDs including ischaemic heart...

Full description

Bibliographic Details
Main Authors: Shiraz Hashmi, Mian Kamal Mustafa, Irfan Khan, Haseeb ur Rehman, Syed Shahabuddin, Shahid Sami
Format: Article
Language:English
Published: Pakistan Medical Association 2023-01-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/9078